ArticlePloS one2015

Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.

Fangfang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.